QUOTE AND NEWS
GenEng News  Apr 20  Comment 
The Massachusetts based Foundation Medicine, which develops, manufactures, and sells genomic analysis diagnostics for solid and circulating cancers, has announced a collaboration with the National Cancer Institute (NCI) on the Exceptional...
Cloud Computing  Apr 14  Comment 
The average length of time in the commercial sector between a network security breach and when the detection of that breach is more than 240 days, according to Gregory Touhill, deputy assistant secretary of Cybersecurity Operations and Programs...
Benzinga  Apr 8  Comment 
Lion Biotechnologies, Inc. (Nasdaq: LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced that data from a metastatic cervical cancer study conducted by the...
Benzinga  Apr 1  Comment 
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that Intrexon has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), part of the National Institutes of Health,...
Forbes  Mar 31  Comment 
Through multiple programs aimed at both supply and demand, California has developed the most vibrant market for plug-in electric vehicles (PEVs) in the world. According to the forthcoming update of Navigant Research’s report, Electric Vehicle...
GenEng News  Mar 5  Comment 
Harold Varmus, M.D., said he will be leaving his position as director of the National Cancer Institute (NCI), a post he has held for almost five years, at the end of March. He noted that he will be moving to New York to “pursue scientific work...
FierceBiotech  Mar 2  Comment 
Today, Kite expanded its research and development deal--or CRADA--with some key researchers at the National Cancer Institute to cover additional programs and targeting tools needed to beef up its pipeline during a critical stage of development for...
The Hindu Business Line  Feb 24  Comment 
The US-based Navigant Healthcare, a revenue management consultant and dispute advisory, has acquired Technopark-based RevenueMed, a player in business process management services in healthc...
GenEng News  Dec 5  Comment 
Juno Therapeutics, focused on developing cell-based immunotherapies based on its chimeric antigen receptor (CAR) and high-affinity T cell, inked a deal to obtain a license from National Cancer Institute (NCI) partner Opus Bio for a CAR-T cell...




 

You may also be interested in articles related to Navigant Consulting:




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki